Presentation Combined General Meeting of Shareholders on second call – June, 25th 2020

Theradiag will hold its General Meeting by conference call on Thursday, June 25 at 14:00 p.m.To participate, please dial +331.70.71.01.59 followed by the participant PIN code 92 21 52 68 #.The presentation is available above…

Continue ReadingPresentation Combined General Meeting of Shareholders on second call – June, 25th 2020

08/06/2020 : Update on Covid-19 test activity and first Theradiag labeled tests CE marked

Croissy-Beaubourg, June 8, 8:15am CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today provides an update on its new Covid-19 test program launched in response to the…

Continue Reading08/06/2020 : Update on Covid-19 test activity and first Theradiag labeled tests CE marked

18/05/2020 : Theradiag: Approval of a first Covid-19 test, ‘RT-PCR’.

Croissy-Beaubourg, May 18, 2020, 7:30pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), specializes in in vitro diagnostics and theranostics. Regarding the new Covid-19 testing activity recently initiated, Theradiag confirms that the viremia test developed by…

Continue Reading18/05/2020 : Theradiag: Approval of a first Covid-19 test, ‘RT-PCR’.